On the bright side...Management giving themselves these options on the same day they mailed the FDA review package is a good sign and not a coincidence (I don't believe in coincidences). They are telling us something.
They wouldn't be giving themselves these options if they were not 100% confident of resolution and Grand Slam Trilogy 2 results.
So there is a very nice silver lining in this, especially that the previous options they had given themselves are really worthless for now.
I'm still confident of my position that this stock is a 5 bagger once Trilogy 2 is announced and a 10 bagger if we get bought or go to market with a partner.
There is a lot of money to be made here, keep your eyes on the prize and be patient for 6-8 months. We will wake up one day soon on the day Trilogy 2 is released and the stock will pop to 3.00$ overnight.